US Presidential Field Narrows, But Ranking The Candidates For Pharma Is Still Complicated

 
• By Michael McCaughan

It is easy to see why Sen. Bernie Sanders would be the least popular pick for biopharma executives among the contenders in the Presidential race. But for industry lobbyists, it might not be the worst outcome – at least in terms of clarifying positions.

Sanders-Biden_illustration_1660450003_1200.jpg
There are now two viable candidates for the Democratic Presidential nomination: Bernie Sanders and Joe Biden. • Source: Shutterstock

More from Pricing Debate

More from Market Access